Imaging prostate cancer (PCa) with [99m Tc(CO)3 ]finasteride dithiocarbamate
| Autor: | Gul-e-Raana, Syed Qaiser Shah, Ghias Uddin |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Biodistribution Biochemistry High-performance liquid chromatography Analytical Chemistry 03 medical and health sciences Prostate cancer chemistry.chemical_compound 0302 clinical medicine In vivo Prostate Drug Discovery medicine Radiology Nuclear Medicine and imaging Dithiocarbamate Spectroscopy chemistry.chemical_classification Chemistry Organic Chemistry medicine.disease Imaging agent 030104 developmental biology medicine.anatomical_structure 030220 oncology & carcinogenesis Finasteride Nuclear chemistry |
| Zdroj: | Journal of Labelled Compounds and Radiopharmaceuticals. 61:550-556 |
| ISSN: | 0362-4803 |
| Popis: | This investigation aimed to modify finasteride (1) to finasteride dithiocarbamate (2) for subsequent synthesis of the rhenium analogue (3) and [99m Tc]tricarbonyl complexes (4), to assess its prostate cancer (PCa) targeting potential in a rat model. To validate the identity of (4), reference (3) has been synthesized by using fac-[Net4 ]2 [ReBr3 (CO)3 ] precursor and characterized by 1 H-NMR, 13 C-NMR, ESI-MS, and elemental analysis. The analogue (4) was synthesized by using fac-[99m Tc(H2 O)3 (CO)3 ]+ precursor, and its structure was confirmed by comparative HPLC by using (3) as a reference. Further, the suitability of (4) as a PCa imaging agent was investigated in vitro and in vivo. At room temperature, (4) had ≥99% radiochemical purity and remained ≥84% stable in serum. In preclinical studies, biodistribution of (4) in histopathologically established rat model showed adequately high in vivo uptake in the prostate attracting the possibility of using it for noninvasive imaging of PCa. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |